BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32681499)

  • 21. Defining the pathogenicity of creatine deficiency syndrome.
    Alcaide P; Merinero B; Ruiz-Sala P; Richard E; Navarrete R; Arias A; Ribes A; Artuch R; Campistol J; Ugarte M; Rodríguez-Pombo P
    Hum Mutat; 2011 Mar; 32(3):282-91. PubMed ID: 21140503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Creatine Transporter Deficiency Presenting as Autism Spectrum Disorder.
    Yıldız Y; Göçmen R; Yaramış A; Coşkun T; Haliloğlu G
    Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33093139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classification of the Molecular Defects Associated with Pathogenic Variants of the
    Salazar MD; Zelt NB; Saldivar R; Kuntz CP; Chen S; Penn WD; Bonneau R; Koehler Leman J; Schlebach JP
    Biochemistry; 2020 Apr; 59(13):1367-1377. PubMed ID: 32207963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts.
    Gorshkov K; Wang AQ; Sun W; Fisher E; Frigeni M; Singleton M; Thorne N; Class B; Huang W; Longo N; Do MT; Ottinger EA; Xu X; Zheng W
    Pharmacol Res Perspect; 2019 Dec; 7(6):e00525. PubMed ID: 31859463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simple screening method using ion chromatography for the diagnosis of cerebral creatine deficiency syndromes.
    Wada T; Shimbo H; Osaka H
    Amino Acids; 2012 Aug; 43(2):993-7. PubMed ID: 22080216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine screening for patients with developmental disabilities detected a patient with creatine transporter deficiency due to a novel missense mutation in SLC6A8.
    Kato H; Miyake F; Shimbo H; Ohya M; Sugawara H; Aida N; Anzai R; Takagi M; Okuda M; Takano K; Wada T; Iai M; Yamashita S; Osaka H
    Brain Dev; 2014 Aug; 36(7):630-3. PubMed ID: 24045174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Preclinical Models in Creatine Transporter Deficiency: Neurobiological Mechanisms, Biomarkers and Therapeutic Development.
    Ghirardini E; Calugi F; Sagona G; Di Vetta F; Palma M; Battini R; Cioni G; Pizzorusso T; Baroncelli L
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A family with creatine transporter deficiency diagnosed with urinary creatine/creatinine ratio and the family history: the third Japanese familial case].
    Nozaki F; Kumada T; Shibata M; Fujii T; Wada T; Osaka H
    No To Hattatsu; 2015 Jan; 47(1):49-52. PubMed ID: 25803912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The screening of SLC6A8 deficiency among Estonian families with X-linked mental retardation.
    Puusepp H; Kall K; Salomons GS; Talvik I; Männamaa M; Rein R; Jakobs C; Õunap K
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S5-11. PubMed ID: 24137762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic variability in a portuguese family with x-linked creatine transport deficiency.
    Garcia P; Rodrigues F; Valongo C; Salomons GS; Diogo L
    Pediatr Neurol; 2012 Jan; 46(1):39-41. PubMed ID: 22196490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral creatine deficiencies: a group of treatable intellectual developmental disorders.
    Stockler-Ipsiroglu S; van Karnebeek CD
    Semin Neurol; 2014 Jul; 34(3):350-6. PubMed ID: 25192512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1H MR spectroscopy as a diagnostic tool for cerebral creatine deficiency.
    Dezortova M; Jiru F; Petrasek J; Malinova V; Zeman J; Jirsa M; Hajek M
    MAGMA; 2008 Sep; 21(5):327-32. PubMed ID: 18726626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of a novel intragenic rearrangement in the creatine transporter gene by next generation sequencing.
    Yu H; van Karnebeek C; Sinclair G; Hill A; Cui H; Zhang VW; Wong LJ
    Mol Genet Metab; 2013 Dec; 110(4):465-71. PubMed ID: 24140398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology.
    Stockler S; Schutz PW; Salomons GS
    Subcell Biochem; 2007; 46():149-66. PubMed ID: 18652076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disorders of creatine transport and metabolism.
    Longo N; Ardon O; Vanzo R; Schwartz E; Pasquali M
    Am J Med Genet C Semin Med Genet; 2011 Feb; 157C(1):72-8. PubMed ID: 21308988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of X-linked creatine transporter (SLC6A8) deficiency: systematic review of the literature and three new cases.
    Dunbar M; Jaggumantri S; Sargent M; Stockler-Ipsiroglu S; van Karnebeek CD
    Mol Genet Metab; 2014 Aug; 112(4):259-74. PubMed ID: 24953403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotype and genotype in 101 males with X-linked creatine transporter deficiency.
    van de Kamp JM; Betsalel OT; Mercimek-Mahmutoglu S; Abulhoul L; Grünewald S; Anselm I; Azzouz H; Bratkovic D; de Brouwer A; Hamel B; Kleefstra T; Yntema H; Campistol J; Vilaseca MA; Cheillan D; D'Hooghe M; Diogo L; Garcia P; Valongo C; Fonseca M; Frints S; Wilcken B; von der Haar S; Meijers-Heijboer HE; Hofstede F; Johnson D; Kant SG; Lion-Francois L; Pitelet G; Longo N; Maat-Kievit JA; Monteiro JP; Munnich A; Muntau AC; Nassogne MC; Osaka H; Ounap K; Pinard JM; Quijano-Roy S; Poggenburg I; Poplawski N; Abdul-Rahman O; Ribes A; Arias A; Yaplito-Lee J; Schulze A; Schwartz CE; Schwenger S; Soares G; Sznajer Y; Valayannopoulos V; Van Esch H; Waltz S; Wamelink MM; Pouwels PJ; Errami A; van der Knaap MS; Jakobs C; Mancini GM; Salomons GS
    J Med Genet; 2013 Jul; 50(7):463-72. PubMed ID: 23644449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Creatine Transporter (SLC6A8) Deficiency With Oral S-Adenosyl Methionine as Adjunct to L-arginine, Glycine, and Creatine Supplements.
    Jaggumantri S; Dunbar M; Edgar V; Mignone C; Newlove T; Elango R; Collet JP; Sargent M; Stockler-Ipsiroglu S; van Karnebeek CD
    Pediatr Neurol; 2015 Oct; 53(4):360-363.e2. PubMed ID: 26205312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. X-linked creatine transporter deficiency: clinical aspects and pathophysiology.
    van de Kamp JM; Mancini GM; Salomons GS
    J Inherit Metab Dis; 2014 Sep; 37(5):715-33. PubMed ID: 24789340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of wild-type creatine transporter (SLC6A8) restores creatine uptake in primary SLC6A8-deficient fibroblasts.
    Rosenberg EH; Muñoz CM; Degrauw TJ; Jakobs Cn; Salomons GS
    J Inherit Metab Dis; 2006; 29(2-3):345-6. PubMed ID: 16763899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.